News for 'elys'

Gurugram Busts Racket Making Fake Diabetes Injections

Gurugram Busts Racket Making Fake Diabetes Injections

Rediff.com1 days ago

Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Rediff.com8 Apr 2026

Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.

Premier League: Bournemouth stun Arsenal to open title race

Premier League: Bournemouth stun Arsenal to open title race

Rediff.com11 Apr 2026

Bournemouth defeated Arsenal 2-1 at the Emirates, throwing the Premier League title race wide open and boosting Manchester City's chances.

Premier League: Liverpool end losing run; Arsenal get title jolt

Premier League: Liverpool end losing run; Arsenal get title jolt

Rediff.com12 Apr 2026

Arsenal's title hopes suffer a blow with a home defeat to Bournemouth, while Liverpool strengthens their Champions League aspirations with a win over Fulham. Brentford and Everton draw in a battle of top-five contenders.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Dhurandhar Actor Krystal D'Souza's Dishy Glamour

Dhurandhar Actor Krystal D'Souza's Dishy Glamour

Rediff.com31 Mar 2026

So what if the mercury is soaring? Our favourite divas never disappoint when it comes to fashion! Namrata Thakker looks at the divas who served glam goals this March.

Djokovic says Serena Williams could make a comeback at Wimbledon

Djokovic says Serena Williams could make a comeback at Wimbledon

Rediff.com5 Mar 2026

Novak Djokovic suggested that Serena Williams could see Wimbledon as the ideal venue to return to tennis.

Weight Loss Drugs Set to Flood India

Weight Loss Drugs Set to Flood India

Rediff.com16 Mar 2026

While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Amelia Valverde appointed head coach of Indian women's football team

Amelia Valverde appointed head coach of Indian women's football team

Rediff.com20 Jan 2026

Amelia Valverde named coach of Indian senior women's football team

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Gurugram Dethrones Mumbai As India's Luxury Housing Capital

Rediff.com24 Feb 2026

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025, recording 24,120 crore in sales of homes priced above 10 crore.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Rare-Disease, Cancer Drugs Get Cheaper

Rare-Disease, Cancer Drugs Get Cheaper

Rediff.com3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

Manchester United, Bournemouth in thrilling eight-goal draw!

Manchester United, Bournemouth in thrilling eight-goal draw!

Rediff.com16 Dec 2025

Bournemouth's Eli Junior Kroupi struck late to salvage a point for his side in a 4-4 draw with Manchester United on Monday.

Weightloss Drugs Hit 1,000 Crore Mark

Weightloss Drugs Hit 1,000 Crore Mark

Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'

PIX: Arsenal extend lead, Aston Villa surge into second

PIX: Arsenal extend lead, Aston Villa surge into second

Rediff.com4 Jan 2026

Arsenal beat Bournemouth 3-2 on Saturday to extend their lead at the top of the English Premier League.

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

Ozempic launched in India, priced at Rs 2,200 per week

Ozempic launched in India, priced at Rs 2,200 per week

Rediff.com12 Dec 2025

Danish pharma major Novo Nordisk on Friday launched its blockbuster type 2 diabetes treatment injection Ozempic, globally popular for its weight-loss benefits.

Priyanka Chopra's Stunning Sari Moments

Priyanka Chopra's Stunning Sari Moments

Rediff.com14 Nov 2025

Ever since she shifted base to the US, Bollywood has been missing its desi girl and her saris.

Sreeleela, Alia, Ananya's Stunning Wedding Fashion

Sreeleela, Alia, Ananya's Stunning Wedding Fashion

Rediff.com18 Nov 2025

The wedding season is on, and it's time to turn up the style quotient and spice things up.

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Weight Loss Drug Mounjaro Registers Rs 80 Cr Sales

Rediff.com8 Oct 2025

The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.

PM-VBRY: What Job Seekers Need To Know

PM-VBRY: What Job Seekers Need To Know

Rediff.com18 Aug 2025

'To encourage the habit of saving, a portion of the incentive will be kept in a savings instrument of deposit account for a fixed period and can be withdrawn by the employee at a later date.'

PIX: Arsenal stay top; Haaland on fire for Manchester City

PIX: Arsenal stay top; Haaland on fire for Manchester City

Rediff.com19 Oct 2025

Erling Haaland took his league tally this season to 11 in eight games with both goals in City's 2-0 home win over Everton -- a result that temporarily put City above Arsenal on goals scored.

Serena Williams shocks fans with 31-pound makeover

Serena Williams shocks fans with 31-pound makeover

Rediff.com22 Aug 2025

The 23-time Grand Slam champion, who retired from professional tennis in 2022, will headline a multi-year national marketing campaign for GLP-1 drugs, a company spokesperson said.

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Govt unveils Rs 2 trillion dose for jobs, R&D, innovation, growth push

Rediff.com2 Jul 2025

In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Weight-Loss Drug Battle Intensifies

Weight-Loss Drug Battle Intensifies

Rediff.com22 Jul 2025

'Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five times what it was five years ago.'

Israeli police to question Netanyahu, 2 aides arrested

Israeli police to question Netanyahu, 2 aides arrested

Rediff.com31 Mar 2025

Two key advisers to Prime Minister Benjamin Netanyahu, Yonatan Urich and Eli Feldstein, were arrested on Monday as part of an ongoing investigation into potential connections between Israeli officials and Qatar.

Public life likely to be hit as over 25 crore workers call 'Bharat Bandh' on Wednesday

Public life likely to be hit as over 25 crore workers call 'Bharat Bandh' on Wednesday

Rediff.com8 Jul 2025

More than 25 crore workers engaged in sectors ranging from banking, insurance, postal to coal mining, highway and construction are expected to go on a nationwide general strike on Wednesday, potentially disrupting services across the country. A forum of 10 central trade unions and their associates has called for a general strike or 'Bharat Bandh' to "oppose the anti-worker, anti-farmer and anti-national pro-corporate policies of the government".

Iranian Missiles Cause Damage In Israel

Iranian Missiles Cause Damage In Israel

Rediff.com14 Jun 2025

Iran fired around 200 ballistic missiles and drones at Israel on Saturday, June 14, 2025, causing widespread damage in communities in north Israel, killing three people and injuring dozens.

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Mounjaro, weight-loss, type 2 diabetes drug, launched in India

Rediff.com20 Mar 2025

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

Sonam Kapoor's Unforgettable Fashion Moments

Sonam Kapoor's Unforgettable Fashion Moments

Rediff.com9 Jun 2025

There is nothing, when it comes to clothes, that Sonam cannot wear well. Nor are there fashion rules that she won't break if need be.

Sonam, Shanaya, Rhea Woo Paris

Sonam, Shanaya, Rhea Woo Paris

Rediff.com30 Jan 2025

The Kapoor sisters, Sonam, Rhea and Shanaya were guests at the invite-only Paris Haute Couture Fashion Week shows.

Eli Lilly plans alliances

Eli Lilly plans alliances

Rediff.com30 May 2007

The US-based drug maker Eli Lilly and Company will form strategic drug manufacturing and development alliances with major Indian pharmaceutical companies to tap the opportunities in contract research and manufacturing.

Hush money case: Trump to be sentenced on Jan 10 but won't face jail term

Hush money case: Trump to be sentenced on Jan 10 but won't face jail term

Rediff.com4 Jan 2025

The judge also added that Trump will face no legal penalties for his conviction in the case, CNN reported.

Job creation gets Budget boost with incentives

Job creation gets Budget boost with incentives

Rediff.com24 Jul 2024

Recognising job creation for the youth as the foremost challenge for the economy, Finance Minister Nirmala Sitharaman on Tuesday announced a comprehensive Prime Minister's package to facilitate the employment and skilling of 41 million youth with a central outlay of Rs 2 trillion over the next five-year period. The package will consist of five schemes and initiatives - three focused on jobs and two on skilling.

Govt May Save Over Rs 70K Cr In FY25

Govt May Save Over Rs 70K Cr In FY25

Rediff.com20 Jan 2025

The government may save over Rs 70,000 crore (Rs 700 billion) on capital and revenue expenditure allocated towards new schemes in the FY25 Budget that are yet to be implemented.